These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25057819)

  • 1. Quantifying a nonnotifiable disease in the United States: the National Amyotrophic Lateral Sclerosis Registry model.
    Horton DK; Mehta P; Antao VC
    JAMA; 2014 Sep; 312(11):1097-8. PubMed ID: 25057819
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
    Mehta P; Kaye W; Bryan L; Larson T; Copeland T; Wu J; Muravov O; Horton K
    MMWR Surveill Summ; 2016 Aug; 65(8):1-12. PubMed ID: 27490513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Mehta P; Antao V; Kaye W; Sanchez M; Williamson D; Bryan L; Muravov O; Horton K; ;
    MMWR Suppl; 2014 Jul; 63(7):1-14. PubMed ID: 25054277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Registry of Veterans with amyotrophic lateral sclerosis.
    Allen KD; Kasarskis EJ; Bedlack RS; Rozear MP; Morgenlander JC; Sabet A; Sams L; Lindquist JH; Harrelson ML; Coffman CJ; Oddone EZ
    Neuroepidemiology; 2008; 30(3):180-90. PubMed ID: 18421218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A brief report on juvenile amyotrophic lateral sclerosis cases in the United States National ALS Registry: 2010-2018.
    Raymond J; Berry J; Kasarskis EJ; Larson T; Horton DK; Mehta P
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):211-213. PubMed ID: 37789566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the Prevalence of Amyotrophic Lateral Sclerosis in the United States Using National Administrative Healthcare Data from 2002 to 2004 and Capture-Recapture Methodology.
    Nelson LM; Topol B; Kaye W; Williamson D; Horton DK; Mehta P; Wagner T
    Neuroepidemiology; 2018; 51(3-4):149-157. PubMed ID: 30092573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016.
    Mehta P; Raymond J; Punjani R; Larson T; Han M; Bove F; Horton DK
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):378-382. PubMed ID: 35023792
    [No Abstract]   [Full Text] [Related]  

  • 8. The underestimation of familial ALS and counseling patients with sporadic ALS.
    Armon C
    Neurology; 2014 Jan; 82(1):13-4. PubMed ID: 24306003
    [No Abstract]   [Full Text] [Related]  

  • 9. National amyotrophic lateral sclerosis case registry.
    Varon MI
    JAMA; 1979 Jun; 241(22):2379. PubMed ID: 439312
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016.
    Mehta P; Raymond J; Punjani R; Larson T; Bove F; Kaye W; Nelson LM; Topol B; Han M; Muravov O; Genson C; Davis B; Hicks T; Horton K
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):220-225. PubMed ID: 34423697
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Am J Public Health; 2015 Jun; 105(6):e7-9. PubMed ID: 25970478
    [No Abstract]   [Full Text] [Related]  

  • 12. The National Registry of Veterans with Amyotrophic Lateral Sclerosis: Department of Veterans Affairs Cooperative Studies Program (CSP) #500a.
    Kasarkis EJ; Dominic K; Oddone EZ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():129-32. PubMed ID: 15512895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance.
    Wagner L; Rechtman L; Jordan H; Ritsick M; Sanchez M; Sorenson E; Kaye W
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):128-34. PubMed ID: 26399278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Completeness of ALS Case Ascertainment in the US National ALS Registry: Application of the Capture-Recapture Method.
    Nelson LM; Topol B; Kaye W; Raymond J; Horton DK; Mehta P; Wagner T
    Neuroepidemiology; 2022; 56(2):104-114. PubMed ID: 34929703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.
    Al-Chalabi A; Calvo A; Chio A; Colville S; Ellis CM; Hardiman O; Heverin M; Howard RS; Huisman MHB; Keren N; Leigh PN; Mazzini L; Mora G; Orrell RW; Rooney J; Scott KM; Scotton WJ; Seelen M; Shaw CE; Sidle KS; Swingler R; Tsuda M; Veldink JH; Visser AE; van den Berg LH; Pearce N
    Lancet Neurol; 2014 Nov; 13(11):1108-1113. PubMed ID: 25300936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis: new ideas from cancer.
    Logroscino G; Ludolph A
    Lancet Neurol; 2014 Nov; 13(11):1067-1068. PubMed ID: 25300935
    [No Abstract]   [Full Text] [Related]  

  • 17. Feasibility of creating a National ALS Registry using administrative data in the United States.
    Kaye WE; Sanchez M; Wu J
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):433-9. PubMed ID: 24597459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National registry offers new hope for ALS.
    Lancet Neurol; 2009 Jan; 8(1):1. PubMed ID: 19081498
    [No Abstract]   [Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis in Catalonia: a population based study.
    Pradas J; Puig T; Rojas-García R; Viguera ML; Gich I; Logroscino G;
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14(4):278-83. PubMed ID: 23286747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the completeness of the national ALS registry, United States.
    Kaye WE; Wagner L; Wu R; Mehta P
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):112-117. PubMed ID: 29020837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.